日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD153/CD30 signaling promotes age-dependent tertiary lymphoid tissue expansion and kidney injury

CD153/CD30信号通路促进与年龄相关的三级淋巴组织扩张和肾损伤

Yuki Sato ,Akiko Oguchi ,Yuji Fukushima ,Kyoko Masuda ,Naoya Toriu ,Keisuke Taniguchi ,Takahisa Yoshikawa ,Xiaotong Cui ,Makiko Kondo ,Takeshi Hosoi ,Shota Komidori ,Yoko Shimizu ,Harumi Fujita ,Li Jiang ,Yingyi Kong ,Takashi Yamanashi ,Jun Seita ,Takuya Yamamoto ,Shinya Toyokuni ,Yoko Hamazaki ,Masakazu Hattori ,Yasunobu Yoshikai ,Peter Boor ,Jürgen Floege ,Hiroshi Kawamoto ,Yasuhiro Murakawa ,Nagahiro Minato ,Motoko Yanagita

ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents

ERG 失调会诱导前列腺癌细胞中的 IGF-1R 表达并影响对抗 IGF-1R 药物的敏感性

Caterina Mancarella, Irene Casanova-Salas, Ana Calatrava, Selena Ventura, Cecilia Garofalo, José Rubio-Briones, Vera Magistroni, Maria Cristina Manara, José Antonio López-Guerrero, Katia Scotlandi

Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide

贝沙罗汀与类视黄醇CD1530联用可降低致癌物4-硝基喹啉-1-氧化物诱导的小鼠口腔癌发生率。

Tang, Xiao-Han; Osei-Sarfo, Kwame; Urvalek, Alison M; Zhang, Tuo; Scognamiglio, Theresa; Gudas, Lorraine J

Antitumor effects and molecular mechanisms of figitumumab, a humanized monoclonal antibody to IGF-1 receptor, in esophageal carcinoma

人源化IGF-1受体单克隆抗体figitumumab对食管癌的抗肿瘤作用及分子机制

Tiehong Zhang, Hongchang Shen, Wei Dong, Xiao Qu, Qi Liu, Jiajun Du

Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance

NVP-AEW541 治疗胆道癌:作用机制和耐药性

Samuel Wolf, Jana Lorenz, Joachim Mössner, Marcus Wiedmann

Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma

基底细胞癌中表达CD30配体/CD153和TNF-α的肥大细胞增加

Diaconu, Nicolae-Costin; Kaminska, Renata; Naukkarinen, Anita; Harvima, Rauno J; Nilsson, Gunnar; Harvima, Ilkka T